Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 336

1.

Surgery for Renal Hyperparathyroidism in the Era of Cinacalcet: A Single-Center Experience.

Mogl MT, Skachko T, Dobrindt EM, Reinke P, Bures C, Pratschke J, Rayes N.

Scand J Surg. 2020 Jan 6:1457496919897004. doi: 10.1177/1457496919897004. [Epub ahead of print]

PMID:
31906794
2.

The TreaT-Assay: A Novel Urine-Derived Donor Kidney Cell-Based Assay for Prediction of Kidney Transplantation Outcome.

Thieme CJ, Weist BJD, Mueskes A, Roch T, Stervbo U, Rosiewicz K, Wehler P, Stein M, Nickel P, Kurtz A, Lachmann N, Choi M, Schmueck-Henneresse M, Westhoff TH, Reinke P, Babel N.

Sci Rep. 2019 Dec 13;9(1):19037. doi: 10.1038/s41598-019-55442-x.

3.

Corrigendum to "VEGF - Supplemented extracellular matrix is sufficient to induce endothelial differentiation of human iPSC" [Biomaterials 216 (2019) 119283 1-10].

Ullah I, Abu-Dawud R, Busch JF, Rabien A, Erguen B, Fischer I, Reinke P, Kurtz A.

Biomaterials. 2020 Feb;230:119660. doi: 10.1016/j.biomaterials.2019.119660. Epub 2019 Dec 5. No abstract available.

4.

Mechanisms of Immune Tolerance in Liver Transplantation-Crosstalk Between Alloreactive T Cells and Liver Cells With Therapeutic Prospects.

Lei H, Reinke P, Volk HD, Lv Y, Wu R.

Front Immunol. 2019 Nov 19;10:2667. doi: 10.3389/fimmu.2019.02667. eCollection 2019. Review.

5.

Multi-Parameter Analysis of Biobanked Human Bone Marrow Stromal Cells Shows Little Influence for Donor Age and Mild Comorbidities on Phenotypic and Functional Properties.

Andrzejewska A, Catar R, Schoon J, Qazi TH, Sass FA, Jacobi D, Blankenstein A, Reinke S, Krüger D, Streitz M, Schlickeiser S, Richter S, Souidi N, Beez C, Kamhieh-Milz J, Krüger U, Zemojtel T, Jürchott K, Strunk D, Reinke P, Duda G, Moll G, Geissler S.

Front Immunol. 2019 Nov 8;10:2474. doi: 10.3389/fimmu.2019.02474. eCollection 2019.

6.

Asymmetries in social touch-motor and emotional biases on lateral preferences in embracing, cradling and kissing.

Packheiser J, Schmitz J, Metzen D, Reinke P, Radtke F, Friedrich P, Güntürkün O, Peterburs J, Ocklenburg S.

Laterality. 2019 Nov 18:1-24. doi: 10.1080/1357650X.2019.1690496. [Epub ahead of print]

PMID:
31739761
7.

Heterologous Cytomegalovirus and Allo-Reactivity by Shared T Cell Receptor Repertoire in Kidney Transplantation.

Stranavova L, Pelak O, Svaton M, Hruba P, Fronkova E, Slavcev A, Osickova K, Maluskova J, Hubacek P, Fronek J, Reinke P, Volk HD, Kalina T, Viklicky O.

Front Immunol. 2019 Oct 31;10:2549. doi: 10.3389/fimmu.2019.02549. eCollection 2019.

8.
9.

Targeting CD20+ B-lymphocytes in inflammatory dilated cardiomyopathy with rituximab improves clinical course: a case series.

Tschöpe C, Van Linthout S, Spillmann F, Posch MG, Reinke P, Volk HD, Elsanhoury A, Kühl U.

Eur Heart J Case Rep. 2019 Sep 1;3(3). pii: ytz131. doi: 10.1093/ehjcr/ytz131.

10.

Intensive blood pressure control is associated with improved patient and graft survival after renal transplantation.

Pagonas N, Bauer F, Seibert FS, Seidel M, Schenker P, Kykalos S, Dürr M, Reinke P, Babel N, Viebahn R, Westhoff TH.

Sci Rep. 2019 Jul 19;9(1):10507. doi: 10.1038/s41598-019-46991-2.

11.

VEGF - Supplemented extracellular matrix is sufficient to induce endothelial differentiation of human iPSC.

Ullah I, Abu-Dawud R, Busch JF, Rabien A, Erguen B, Fischer I, Reinke P, Kurtz A.

Biomaterials. 2019 Sep;216:119283. doi: 10.1016/j.biomaterials.2019.119283. Epub 2019 Jun 18. Erratum in: Biomaterials. 2020 Feb;230:119660.

12.

Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study.

Ziemann M, Altermann W, Angert K, Arns W, Bachmann A, Bakchoul T, Banas B, von Borstel A, Budde K, Ditt V, Einecke G, Eisenberger U, Feldkamp T, Görg S, Guthoff M, Habicht A, Hallensleben M, Heinemann FM, Hessler N, Hugo C, Kaufmann M, Kauke T, Koch M, König IR, Kurschat C, Lehmann C, Marget M, Mühlfeld A, Nitschke M, Pego da Silva L, Quick C, Rahmel A, Rath T, Reinke P, Renders L, Sommer F, Spriewald B, Staeck O, Stippel D, Süsal C, Thiele B, Zecher D, Lachmann N.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1056-1066. doi: 10.2215/CJN.13401118. Epub 2019 Jun 18.

PMID:
31213508
13.

Cytotoxic Effects of Rabbit Anti-thymocyte Globulin Preparations on Primary Human Thymic Epithelial Cells.

Kaebisch EM, Cho MY, Oh YS, Olfe LI, Szyska M, Becker SC, Reinke P, Volk HD, Gillissen B, Bullinger L, Thiel A, Na IK.

Transplantation. 2019 Nov;103(11):2234-2244. doi: 10.1097/TP.0000000000002799.

PMID:
31205263
14.

Comprehensive Characterization of a Next-Generation Antiviral T-Cell Product and Feasibility for Application in Immunosuppressed Transplant Patients.

Amini L, Vollmer T, Wendering DJ, Jurisch A, Landwehr-Kenzel S, Otto NM, Jürchott K, Volk HD, Reinke P, Schmueck-Henneresse M.

Front Immunol. 2019 May 28;10:1148. doi: 10.3389/fimmu.2019.01148. eCollection 2019.

15.

Effects of expanded allocation programmes and organ and recipient quality metrics on transplant-related costs in kidney transplantation - an institutional analysis.

Dziodzio T, Jara M, Hardt J, Weiss S, Ritschl PV, Denecke C, Biebl M, Gerlach U, Reinke P, Pratschke J, Öllinger R.

Transpl Int. 2019 Oct;32(10):1074-1084. doi: 10.1111/tri.13463. Epub 2019 Jun 6.

PMID:
31099091
16.

The Identity Card of T Cells-Clinical Utility of T-cell Receptor Repertoire Analysis in Transplantation.

Babel N, Stervbo U, Reinke P, Volk HD.

Transplantation. 2019 Aug;103(8):1544-1555. doi: 10.1097/TP.0000000000002776.

PMID:
31033649
17.

A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantation.

Wittenbrink N, Herrmann S, Blazquez-Navarro A, Bauer C, Lindberg E, Wolk K, Sabat R, Reinke P, Sawitzki B, Thomusch O, Hugo C, Babel N, Seitz H, Or-Guil M.

BMC Immunol. 2019 Apr 27;20(1):11. doi: 10.1186/s12865-019-0291-2.

18.

BKV Clearance Time Correlates With Exhaustion State and T-Cell Receptor Repertoire Shape of BKV-Specific T-Cells in Renal Transplant Patients.

Stervbo U, Nienen M, Weist BJD, Kuchenbecker L, Hecht J, Wehler P, Westhoff TH, Reinke P, Babel N.

Front Immunol. 2019 Apr 10;10:767. doi: 10.3389/fimmu.2019.00767. eCollection 2019.

19.

The Role of Pre-existing Cross-Reactive Central Memory CD4 T-Cells in Vaccination With Previously Unseen Influenza Strains.

Nienen M, Stervbo U, Mölder F, Kaliszczyk S, Kuchenbecker L, Gayova L, Schweiger B, Jürchott K, Hecht J, Neumann AU, Rahmann S, Westhoff T, Reinke P, Thiel A, Babel N.

Front Immunol. 2019 Apr 4;10:593. doi: 10.3389/fimmu.2019.00593. eCollection 2019.

20.

The Value of a Rapid Test of Human Regulatory T Cell Function Needs to be Revised.

Wendering DJ, Amini L, Schlickeiser S, Reinke P, Volk HD, Schmueck-Henneresse M.

Front Immunol. 2019 Feb 5;10:150. doi: 10.3389/fimmu.2019.00150. eCollection 2019.

21.

Generating Multiple Kidney Progenitors and Cell Types from Human Pluripotent Stem Cells.

Hariharan K, Reinke P, Kurtz A.

Methods Mol Biol. 2019;1926:103-115. doi: 10.1007/978-1-4939-9021-4_9.

PMID:
30742266
22.

Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines.

Moll G, Ankrum JA, Kamhieh-Milz J, Bieback K, Ringdén O, Volk HD, Geissler S, Reinke P.

Trends Mol Med. 2019 Feb;25(2):149-163. doi: 10.1016/j.molmed.2018.12.006. Epub 2019 Jan 30. Review.

23.

From Alloy to Oxide: Capturing the Early Stages of Oxidation on Ni-Cr(100) Alloys.

Blades WH, Reinke P.

ACS Appl Mater Interfaces. 2018 Dec 12;10(49):43219-43229. doi: 10.1021/acsami.8b15210. Epub 2018 Dec 3.

PMID:
30452217
24.

Author Correction: Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia.

Latham SL, Ehmke N, Reinke PYA, Taft MH, Eicke D, Reindl T, Stenzel W, Lyons MJ, Friez MJ, Lee JA, Hecker R, Frühwald MC, Becker K, Neuhann TM, Horn D, Schrock E, Niehaus I, Sarnow K, Grützmann K, Gawehn L, Klink B, Rump A, Chaponnier C, Figueiredo C, Knöfler R, Manstein DJ, Di Donato N.

Nat Commun. 2018 Nov 19;9(1):4930. doi: 10.1038/s41467-018-07404-6.

25.

High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population.

Wagner DL, Amini L, Wendering DJ, Burkhardt LM, Akyüz L, Reinke P, Volk HD, Schmueck-Henneresse M.

Nat Med. 2019 Feb;25(2):242-248. doi: 10.1038/s41591-018-0204-6. Epub 2018 Oct 29.

PMID:
30374197
26.

Rescue from lethal acute radiation syndrome (ARS) with severe weight loss by secretome of intramuscularly injected human placental stromal cells.

Pinzur L, Akyuez L, Levdansky L, Blumenfeld M, Volinsky E, Aberman Z, Reinke P, Ofir R, Volk HD, Gorodetsky R.

J Cachexia Sarcopenia Muscle. 2018 Dec;9(6):1079-1092. doi: 10.1002/jcsm.12342. Epub 2018 Oct 18.

27.

Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia.

Latham SL, Ehmke N, Reinke PYA, Taft MH, Eicke D, Reindl T, Stenzel W, Lyons MJ, Friez MJ, Lee JA, Hecker R, Frühwald MC, Becker K, Neuhann TM, Horn D, Schrock E, Niehaus I, Sarnow K, Grützmann K, Gawehn L, Klink B, Rump A, Chaponnier C, Figueiredo C, Knöfler R, Manstein DJ, Di Donato N.

Nat Commun. 2018 Oct 12;9(1):4250. doi: 10.1038/s41467-018-06713-0. Erratum in: Nat Commun. 2018 Nov 19;9(1):4930.

28.

Parallel generation of easily selectable multiple nephronal cell types from human pluripotent stem cells.

Hariharan K, Stachelscheid H, Rossbach B, Oh SJ, Mah N, Schmidt-Ott K, Kurtz A, Reinke P.

Cell Mol Life Sci. 2019 Jan;76(1):179-192. doi: 10.1007/s00018-018-2929-2. Epub 2018 Oct 11.

PMID:
30310934
29.

Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials.

Sommerer C, Witzke O, Lehner F, Arns W, Reinke P, Eisenberger U, Vogt B, Heller K, Jacobi J, Guba M, Stahl R, Hauser IA, Kliem V, Wüthrich RP, Mühlfeld A, Suwelack B, Duerr M, Paulus EM, Zeier M, Porstner M, Budde K; ZEUS and HERAKLES study investigators.

BMC Nephrol. 2018 Sep 19;19(1):237. doi: 10.1186/s12882-018-1031-1.

30.

Immunomodulatory placental-expanded, mesenchymal stromal cells improve muscle function following hip arthroplasty.

Winkler T, Perka C, von Roth P, Agres AN, Plage H, Preininger B, Pumberger M, Geissler S, Hagai EL, Ofir R, Pinzur L, Eyal E, Stoltenburg-Didinger G, Meisel C, Consentius C, Streitz M, Reinke P, Duda GN, Volk HD.

J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):880-897. doi: 10.1002/jcsm.12316. Epub 2018 Sep 19.

31.

BKV, CMV, and EBV Interactions and their Effect on Graft Function One Year Post-Renal Transplantation: Results from a Large Multi-Centre Study.

Blazquez-Navarro A, Dang-Heine C, Wittenbrink N, Bauer C, Wolk K, Sabat R, Westhoff TH, Sawitzki B, Reinke P, Thomusch O, Hugo C, Or-Guil M, Babel N.

EBioMedicine. 2018 Aug;34:113-121. doi: 10.1016/j.ebiom.2018.07.017. Epub 2018 Jul 30.

32.

Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study.

Eisenberger U, Budde K, Lehner F, Sommerer C, Reinke P, Witzke O, Wüthrich RP, Stahl R, Heller K, Suwelack B, Mühlfeld A, Hauser IA, Nadalin S, Porstner M, Arns W; ZEUS Study Investigators.

BMC Nephrol. 2018 Jun 28;19(1):154. doi: 10.1186/s12882-018-0950-1.

33.

Cyclosporine use and male gender are independent determinants of avascular necrosis after kidney transplantation: a cohort study.

Schachtner T, Otto NM, Reinke P.

Nephrol Dial Transplant. 2018 Nov 1;33(11):2060-2066. doi: 10.1093/ndt/gfy148.

PMID:
29868874
34.

Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis.

Pappritz K, Savvatis K, Miteva K, Kerim B, Dong F, Fechner H, Müller I, Brandt C, Lopez B, González A, Ravassa S, Klingel K, Diez J, Reinke P, Volk HD, Van Linthout S, Tschöpe C.

FASEB J. 2018 Jun 4:fj201701408R. doi: 10.1096/fj.201701408R. [Epub ahead of print]

PMID:
29863913
35.

Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy.

Landwehr-Kenzel S, Zobel A, Hoffmann H, Landwehr N, Schmueck-Henneresse M, Schachtner T, Roemhild A, Reinke P.

Kidney Int. 2018 Jun;93(6):1452-1464. doi: 10.1016/j.kint.2018.01.021.

PMID:
29792274
36.

Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder: A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials.

Zimmermann H, Babel N, Dierickx D, Morschhauser F, Mollee P, Zaucha JM, Dreyling MH, Dührsen U, Reinke P, Verhoef G, Subklewe M, Hüttmann A, Tousseyn T, Bachy E, Hauser IA, Tarella C, Van Den Neste E, Gheysens O, Anagnostopoulos I, Leblond V, Riess H, Choquet S, Trappe RU.

Transplantation. 2018 Nov;102(11):1914-1923. doi: 10.1097/TP.0000000000002269.

PMID:
29757894
37.

Differential T cell response against BK virus regulatory and structural antigens: A viral dynamics modelling approach.

Blazquez-Navarro A, Schachtner T, Stervbo U, Sefrin A, Stein M, Westhoff TH, Reinke P, Klipp E, Babel N, Neumann AU, Or-Guil M.

PLoS Comput Biol. 2018 May 10;14(5):e1005998. doi: 10.1371/journal.pcbi.1005998. eCollection 2018 May.

38.

Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy.

Sommerer C, Duerr M, Witzke O, Lehner F, Arns W, Kliem V, Ackermann D, Guba M, Jacobi J, Hauser IA, Stahl R, Reinke P, Rath T, Veit J, Mehrabi A, Porstner M, Budde K; HERAKLES Study Group.

Am J Transplant. 2018 Dec;18(12):2965-2976. doi: 10.1111/ajt.14897. Epub 2018 Jun 3.

39.

Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME.

Scheibenbogen C, Loebel M, Freitag H, Krueger A, Bauer S, Antelmann M, Doehner W, Scherbakov N, Heidecke H, Reinke P, Volk HD, Grabowski P.

PLoS One. 2018 Mar 15;13(3):e0193672. doi: 10.1371/journal.pone.0193672. eCollection 2018.

40.

Prevalence and Clinical Correlates of Chronic Hepatitis E Infection in German Renal Transplant Recipients With Elevated Liver Enzymes.

Choi M, Hofmann J, Köhler A, Wang B, Bock CT, Schott E, Reinke P, Nickel P.

Transplant Direct. 2018 Feb 2;4(2):e341. doi: 10.1097/TXD.0000000000000758. eCollection 2018 Feb.

41.

Evolution of NiO Island Size Distributions during the Oxidation of a Ni-5Cr Alloy: Experiment and Modeling.

Ramanathan R, Ramalingam G, Perepezko JH, Reinke P, Voorhees PW.

ACS Appl Mater Interfaces. 2018 Mar 14;10(10):9136-9146. doi: 10.1021/acsami.7b18539. Epub 2018 Mar 5.

PMID:
29446919
42.

Transplantectomy is associated with presensitization with donor-reactive T cells and graft failure after kidney retransplantation: a cohort study.

Schachtner T, Otto NM, Stein M, Reinke P.

Nephrol Dial Transplant. 2018 May 1;33(5):889-896. doi: 10.1093/ndt/gfy002.

PMID:
29401311
43.

Factors and outcomes in association with sepsis differ between simultaneous pancreas/kidney and single kidney transplant recipients.

Schachtner T, Zaks M, Otto NM, Kahl A, Reinke P.

Transpl Infect Dis. 2018 Apr;20(2):e12848. doi: 10.1111/tid.12848. Epub 2018 Mar 1.

PMID:
29359836
44.

The effect of induction therapy on established CMV specific T cell immunity in living donor kidney transplantation.

Stranavova L, Hruba P, Girmanova E, Tycova I, Slavcev A, Fronek J, Slatinska J, Reinke P, Volk HD, Viklicky O.

Physiol Res. 2018 May 4;67(2):251-260. Epub 2018 Jan 5.

45.

End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry.

Zimmermann H, Denecke T, Dreyling MH, Franzius C, Reinke P, Subklewe M, Amthauer H, Kneba M, Riess H, Trappe RU.

Transplantation. 2018 May;102(5):868-875. doi: 10.1097/TP.0000000000002006.

PMID:
29189632
46.

Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: Long-term Results After 7 Years of a Randomized Clinical Trial.

Witzke O, Nitschke M, Bartels M, Wolters H, Wolf G, Reinke P, Hauser IA, Alshuth U, Kliem V.

Transplantation. 2018 May;102(5):876-882. doi: 10.1097/TP.0000000000002024.

PMID:
29166336
47.

Pink-beam serial crystallography.

Meents A, Wiedorn MO, Srajer V, Henning R, Sarrou I, Bergtholdt J, Barthelmess M, Reinke PYA, Dierksmeyer D, Tolstikova A, Schaible S, Messerschmidt M, Ogata CM, Kissick DJ, Taft MH, Manstein DJ, Lieske J, Oberthuer D, Fischetti RF, Chapman HN.

Nat Commun. 2017 Nov 3;8(1):1281. doi: 10.1038/s41467-017-01417-3.

48.

Evaluation of adherence and tolerability of prolonged-release tacrolimus (Advagraf™) in kidney transplant patients in Germany: A multicenter, noninterventional study.

Lehner LJ, Reinke P, Hörstrup JH, Rath T, Suwelack B, Krämer BK, Budde K, Banas B.

Clin Transplant. 2018 Jan;32(1). doi: 10.1111/ctr.13142. Epub 2018 Jan 5.

PMID:
29052906
49.

Invited letter in response to "Predicted indirectly recognizable HLA epitopes (PIRCHE): Only the tip of the iceberg?"

Lachmann N, Niemann M, Reinke P, Budde K, Schmidt D, Halleck F, Pruß A, Schönemann C, Spierings E, Staeck O.

Am J Transplant. 2018 Feb;18(2):523-524. doi: 10.1111/ajt.14535. Epub 2017 Nov 4. No abstract available.

50.

Accelerating Patients' Access to Advanced Therapies in the EU.

Elsanhoury A, Sanzenbacher R, Reinke P, Abou-El-Enein M.

Mol Ther Methods Clin Dev. 2017 Sep 22;7:15-19. doi: 10.1016/j.omtm.2017.08.005. eCollection 2017 Dec 15. Review. No abstract available.

Supplemental Content

Loading ...
Support Center